Market Overview

Richmond Brothers and Mark Ravich File Preliminary Proxy on Rockwell Medical, Inc.

Share:





Richmond Brothers, Inc., a Michigan-based SEC registered investment
advisor and wealth management firm that is the largest beneficial owner
of Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell" or the "Company"),
and Mark H. Ravich, who together with their affiliates beneficially own
over 6.1 million shares, or 11.9% of the Company's outstanding common
stock, today commented on their filing of a preliminary proxy statement
in connection with Rockwell's upcoming annual meeting of shareholders.

David S. Richmond, Chairman of Richmond Brothers, Inc., and Mark H.
Ravich issued the following statement:

"Rockwell's most recent announcement regarding its so-called ‘corporate
governance enhancements' appears to be just the Company's latest
defensive and reactionary ploy in response to our involvement, and an
apparent attempt to temporarily distract shareholders from the
underperformance and corporate governance shortcomings that have plagued
the Company for years. In our view, the Company would not have taken
these steps were it not for our involvement – history has shown that the
Company has not been interested in making proactive change absent a
looming proxy contest. We are also concerned that the Company's
newly-acquired interest in improving its corporate governance practices
may be abandoned if a public shareholder representative is not elected
to the Board.

Simply put, we believe Rockwell's announcement is nothing more than
‘window dressing' designed to win the current proxy contest. In our
view, the incumbent leadership team's actions over the years speak much
louder than their recent words. The fact that the Company has filed a
lawsuit against us, for example, belies the lengths to which Rockwell's
leadership will go to keep shareholders' voices out of the boardroom.

Further, Rockwell's historical compensation practices provide yet
another example of the incumbent Board's apparent disinterest in
proactively taking action in the best interests of shareholders. For
instance, Institutional Shareholder Services (ISS), one of the leading
institutional proxy advisory firms, has repeatedly raised high levels of
concern with respect to the alignment of CEO pay and the Company's
performance, noting that Chairman and CEO Robert Chioini's pay was 5.49
times the median of Rockwell's peers in 2014 and 4.61 times the median
of its peers in 2015.1 This is even more troubling when
taking into account the Company's poor performance under his leadership.

Perhaps most troubling to us is the Board's apparent belief that its
2017 equity compensation plan (the "2017 Plan") represents an
improvement to the Company's 2016 equity compensation plan (the "2016
Plan") that shareholders voted down at the 2016 Annual Meeting.

While the 2016 Plan sought to reserve a total of 7,500,000 shares for
issuance under its proposed 10-year life, by our calculations, over 29
million shares could potentially be issued under the 2017 Plan during
its 10-year life, if not more. This amounts to approximately 56% of the
Company's currently outstanding shares. Keep in mind, this would be in
addition to the nearly 15% of the Company that has already been given to
insiders under prior equity plans. In our view, this represents a
completely unacceptable level of potential dilution for shareholders.

The fact that the Board has adopted a plan of this magnitude shows, in
our view, that the incumbent directors are still not making a serious
effort to improve corporate governance. Does anyone actually think the
same old Board will act differently than in years past without a
shareholder representative in the boardroom working hard to stop
outrageous actions such as this?

Rather than focus on the substantial number of shares voting against
both the 2016 Plan and the Compensation Committee Chair last year (when
shareholders registered a 44% disapproval vote on the Chairman of the
Compensation Committee, Ronald Boyd), and seeking to understand its
shareholders' concerns with the Company's compensation plans, the Board
apparently chose to focus, instead, on what it called the low voter
response in 2016 – despite a substantially lower voter response the
prior year. We believe the 2017 Plan, a plan significantly more dilutive
than the 2016 Plan, sets a new low in Board responsiveness to
shareholder concerns.

The real story at Rockwell, we believe, is one of disappointing
performance, management inexperience, lack of successful execution, lack
of regard for shareholders' best interests, and subpar corporate
governance – all of which has characterized the Company for years. In
our view, these issues are the driving factors in Rockwell's terrible
stock price performance over the near and long term. In fact, as the
chart below illustrates, Rockwell has delivered negative returns over
the trailing 1, 3, 5, and 10 years prior to our involvement, and has
underperformed the NASDAQ Biotechnology Index (NBI) Index by a
staggering 315% over the past 10 years.

Total Shareholder Return2

                     
1-Year 3-Year 5-Year 10-Year
RMTI -24.2% -52.5% -38.6% -21.8%
NBI Index     12.5%       12.4%       151.2%       293.2%
RMTI Underperformance     -36.7%       -64.9%       -189.8%       -315%
Source: Bloomberg

Despite the Company's apparent efforts to create an illusion that all is
well at Rockwell, we continue to be committed to electing a director who
will truly represent shareholders' best interests, endeavor to create a
culture of good corporate governance, and properly oversee management at
the Company. We believe Rockwell's recent actions further illustrate the
need for urgent change at the Board level, and we look forward to
continuing to make our case to shareholders in advance of the Annual
Meeting."

For more information, and to see other communications and filings from
Richmond Brothers and Mark Ravich, visit this link: http://www.richmondbrothers.com/time-for-action-at-rmti.

About Richmond Brothers, Inc.

Richmond Brothers, Inc. is an SEC registered investment advisor and
wealth management firm founded in 1994.

About Mark H. Ravich

Mark Ravich is a private investor and currently serves as President of
Tri-Star Management, Inc., a commercial real estate management and
syndication company that he co-founded in 1998.

CERTAIN INFORMATION CONCERNING THE PARTICIPANTS

Richmond Brothers, Inc. ("Richmond Brothers") and Mark H. Ravich,
together with the other participants named herein, have filed a
preliminary proxy statement and accompanying BLUE proxy card with
the Securities and Exchange Commission ("SEC") to be used to solicit
votes for the election of their highly-qualified director nominee at the
2017 annual meeting of shareholders of Rockwell Medical, Inc., a
Michigan corporation (the "Company").

RICHMOND BROTHERS STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO
READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME
AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY
MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SEC'S WEB SITE AT HTTP://WWW.SEC.GOV.
IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE
COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON
REQUEST. REQUESTS FOR COPIES SHOULD BE DIRECTED TO THE PARTICIPANTS'
PROXY SOLICITOR.

The participants in the proxy solicitation are Norman J. Ravich
Irrevocable Trust ("NJR Trust"), Norman and Sally Ravich Family Trust
("NSR Trust"), Alexander Coleman Ravich 1991 Irrevocable Trust ("ACR
Trust"), Alyssa Danielle Ravich 1991 Irrevocable Trust ("ADR Trust"),
Mark H. Ravich, Richmond Brothers, RBI Private Investment I, LLC ("RBI
PI"), RBI Private Investment II, LLC ("RBI PII"), RBI PI Manager, LLC
("RBI Manager"), Richmond Brothers 401(k) Profit Sharing Plan ("RBI
Plan"), David S. Richmond and Matthew J. Curfman.

As of the date hereof, NJR Trust beneficially owned 44,400 shares of
common stock, no par value per share (the "Common Stock"). As of the
date hereof, NSR Trust beneficially owned 18,500 shares of Common Stock,
consisting of shares underlying certain call options. As of the date
hereof, ACR Trust beneficially owned 25,000 shares of Common Stock. As
of the date hereof, ADR Trust beneficially owned 25,000 shares of Common
Stock. As of the date hereof, Mr. Ravich directly beneficially owned
354,750 shares of Common Stock, including 70,000 shares underlying
certain call options. Mr. Ravich, as the trustee of each of NJR Trust,
NSR Trust, ACR Trust and ADR Trust, may be deemed to beneficially own
the 112,900 shares beneficially owned in the aggregate by such trusts.
As of the date hereof, 5,169,177 shares of Common Stock were held in
certain accounts managed by Richmond Brothers (the "Separately Managed
Accounts"). Richmond Brothers, as the investment advisor to the
Separately Managed Accounts, may be deemed to beneficially own the
5,169,177 shares held in the Separately Managed Accounts. As of the date
hereof, RBI PI beneficially owned 164,841 shares of Common Stock. As of
the date hereof, RBI PII beneficially owned 29,802 shares of Common
Stock. RBI Manager, as the manager of RBI PI and RBI PII, may be deemed
to beneficially own the 164,841 shares owned by RBI PI and 29,802 shares
owned by RBI PII. As of the date hereof, RBI Plan beneficially owned
41,495 shares of Common Stock. As of the date hereof, Mr. Richmond
beneficially owned directly 176,412 shares of Common Stock. Mr.
Richmond, as Chairman of Richmond Brothers, manager of RBI Manager and a
trustee of RBI Plan, may also be deemed to beneficially own the
5,169,177 shares held in the Separately Managed Accounts, 164,841 shares
owned by RBI PI, 29,802 shares owned by RBI PII and 41,495 Shares owned
by RBI Plan. Mr. Richmond may also be deemed to beneficially own the
28,096 shares owned directly by his spouse, 147 shares owned directly by
his daughter and 7 shares owned directly by his son. As of the date
hereof, Mr. Curfman beneficially owned directly 40,684 shares of Common
Stock. Mr. Curfman, as President of Richmond Brothers and a trustee of
RBI Plan, may also be deemed to beneficially own the 5,169,177 shares
held in the Separately Managed Accounts and 41,495 Shares owned by RBI
Plan. Mr. Curfman may also be deemed to beneficially own the 34,385
shares owned directly by his spouse.

1 According to ISS reports from Rockwell's past two annual
meetings.

2 Reflects total returns for the trailing 1-, 3-, 5-, and
10-year periods through February 20, 2017 (the day prior to Richmond
Brothers' public involvement with respect to the Company).

View Comments and Join the Discussion!